451 related articles for article (PubMed ID: 29891922)
1. SKP2- and OTUD1-regulated non-proteolytic ubiquitination of YAP promotes YAP nuclear localization and activity.
Yao F; Zhou Z; Kim J; Hang Q; Xiao Z; Ton BN; Chang L; Liu N; Zeng L; Wang W; Wang Y; Zhang P; Hu X; Su X; Liang H; Sun Y; Ma L
Nat Commun; 2018 Jun; 9(1):2269. PubMed ID: 29891922
[TBL] [Abstract][Full Text] [Related]
2. SKP2 and OTUD1 govern non-proteolytic ubiquitination of YAP that promotes YAP nuclear localization and activity.
Yao F; Xiao Z; Sun Y; Ma L
Cell Stress; 2018 Aug; 2(9):233-235. PubMed ID: 31225491
[TBL] [Abstract][Full Text] [Related]
3. The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity.
Shimomura T; Miyamura N; Hata S; Miura R; Hirayama J; Nishina H
Biochem Biophys Res Commun; 2014 Jan; 443(3):917-23. PubMed ID: 24380865
[TBL] [Abstract][Full Text] [Related]
4. Furry protein suppresses nuclear localization of yes-associated protein (YAP) by activating NDR kinase and binding to YAP.
Irie K; Nagai T; Mizuno K
J Biol Chem; 2020 Mar; 295(10):3017-3028. PubMed ID: 31996378
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation.
Lin KC; Moroishi T; Meng Z; Jeong HS; Plouffe SW; Sekido Y; Han J; Park HW; Guan KL
Nat Cell Biol; 2017 Jul; 19(8):996-1002. PubMed ID: 28752853
[TBL] [Abstract][Full Text] [Related]
6. Hippo Signaling Suppresses Cell Ploidy and Tumorigenesis through Skp2.
Zhang S; Chen Q; Liu Q; Li Y; Sun X; Hong L; Ji S; Liu C; Geng J; Zhang W; Lu Z; Yin ZY; Zeng Y; Lin KH; Wu Q; Li Q; Nakayama K; Nakayama KI; Deng X; Johnson RL; Zhu L; Gao D; Chen L; Zhou D
Cancer Cell; 2017 May; 31(5):669-684.e7. PubMed ID: 28486106
[TBL] [Abstract][Full Text] [Related]
7. Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway.
Mo JS; Meng Z; Kim YC; Park HW; Hansen CG; Kim S; Lim DS; Guan KL
Nat Cell Biol; 2015 Apr; 17(4):500-10. PubMed ID: 25751140
[TBL] [Abstract][Full Text] [Related]
8. ZNF213 negatively controls triple negative breast cancer progression via Hippo/YAP signaling.
Liu Y; Su P; Zhao W; Li X; Yang X; Fan J; Yang H; Yan C; Mao L; Ding Y; Zhu J; Niu Z; Zhuang T
Cancer Sci; 2021 Jul; 112(7):2714-2727. PubMed ID: 33939216
[TBL] [Abstract][Full Text] [Related]
9. Dishevelled has a YAP nuclear export function in a tumor suppressor context-dependent manner.
Lee Y; Kim NH; Cho ES; Yang JH; Cha YH; Kang HE; Yun JS; Cho SB; Lee SH; Paclikova P; Radaszkiewicz TW; Bryja V; Kang CG; Yuk YS; Cha SY; Kim SY; Kim HS; Yook JI
Nat Commun; 2018 Jun; 9(1):2301. PubMed ID: 29895829
[TBL] [Abstract][Full Text] [Related]
10. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP).
Zhao B; Li L; Tumaneng K; Wang CY; Guan KL
Genes Dev; 2010 Jan; 24(1):72-85. PubMed ID: 20048001
[TBL] [Abstract][Full Text] [Related]
11. Serum deprivation inhibits the transcriptional co-activator YAP and cell growth via phosphorylation of the 130-kDa isoform of Angiomotin by the LATS1/2 protein kinases.
Adler JJ; Johnson DE; Heller BL; Bringman LR; Ranahan WP; Conwell MD; Sun Y; Hudmon A; Wells CD
Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17368-73. PubMed ID: 24101513
[TBL] [Abstract][Full Text] [Related]
12. Acetylation of VGLL4 Regulates Hippo-YAP Signaling and Postnatal Cardiac Growth.
Lin Z; Guo H; Cao Y; Zohrabian S; Zhou P; Ma Q; VanDusen N; Guo Y; Zhang J; Stevens SM; Liang F; Quan Q; van Gorp PR; Li A; Dos Remedios C; He A; Bezzerides VJ; Pu WT
Dev Cell; 2016 Nov; 39(4):466-479. PubMed ID: 27720608
[TBL] [Abstract][Full Text] [Related]
13. Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung.
Lange AW; Sridharan A; Xu Y; Stripp BR; Perl AK; Whitsett JA
J Mol Cell Biol; 2015 Feb; 7(1):35-47. PubMed ID: 25480985
[TBL] [Abstract][Full Text] [Related]
14. Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides.
Zhou Z; Hu T; Xu Z; Lin Z; Zhang Z; Feng T; Zhu L; Rong Y; Shen H; Luk JM; Zhang X; Qin N
FASEB J; 2015 Feb; 29(2):724-32. PubMed ID: 25384421
[TBL] [Abstract][Full Text] [Related]
15. SCF-SKP2 E3 ubiquitin ligase links mTORC1/ER stress/ISR with YAP activation in murine renal cystogenesis.
Panda DK; Bai X; Zhang Y; Stylianesis NA; Koromilas AE; Lipman ML; Karaplis AC
J Clin Invest; 2022 Dec; 132(24):. PubMed ID: 36326820
[TBL] [Abstract][Full Text] [Related]
16. The nonreceptor tyrosine kinase c-Src attenuates SCF(β-TrCP) E3-ligase activity abrogating Taz proteasomal degradation.
Shanzer M; Adler J; Ricardo-Lax I; Reuven N; Shaul Y
Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1678-1683. PubMed ID: 28154141
[TBL] [Abstract][Full Text] [Related]
17. Homeostatic control of Hippo signaling activity revealed by an endogenous activating mutation in YAP.
Chen Q; Zhang N; Xie R; Wang W; Cai J; Choi KS; David KK; Huang B; Yabuta N; Nojima H; Anders RA; Pan D
Genes Dev; 2015 Jun; 29(12):1285-97. PubMed ID: 26109051
[TBL] [Abstract][Full Text] [Related]
18. RAC-LATS1/2 signaling regulates YAP activity by switching between the YAP-binding partners TEAD4 and RUNX3.
Jang JW; Kim MK; Lee YS; Lee JW; Kim DM; Song SH; Lee JY; Choi BY; Min B; Chi XZ; Bae SC
Oncogene; 2017 Feb; 36(7):999-1011. PubMed ID: 27425596
[TBL] [Abstract][Full Text] [Related]
19. Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis.
Tanaka K; Osada H; Murakami-Tonami Y; Horio Y; Hida T; Sekido Y
Cancer Lett; 2017 Jan; 385():215-224. PubMed ID: 27773750
[TBL] [Abstract][Full Text] [Related]
20. The Hippo Pathway and YAP/TAZ-TEAD Protein-Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment.
Santucci M; Vignudelli T; Ferrari S; Mor M; Scalvini L; Bolognesi ML; Uliassi E; Costi MP
J Med Chem; 2015 Jun; 58(12):4857-73. PubMed ID: 25719868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]